STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICL
  4. [Form 3] ICL Group Ltd. Initial Statement of Beneficial Ownership

ICL (ICL) EVP Global IT discloses over 1.08M share stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

ICL Group Ltd. executive Mishor Miriam, EVP Global IT, reported existing derivative holdings in a Form 3. The filing shows stock options giving rights to acquire 464,902 Ordinary Shares at an exercise price of $9.39 per share, expiring on February 8, 2027; these options are fully vested and exercisable and are held by a Trustee in the reporting person's name.

A second option position covers 620,177 Ordinary Shares at an exercise price of $5.87 per share, expiring on April 4, 2029, vesting in three equal annual installments from the April 4, 2024 grant date. The Form 3 records these as direct beneficial holdings and does not reflect new purchases or sales, but rather the baseline option positions as of the reporting date.

Positive

  • None.

Negative

  • None.
Insider Mishor MIRIAM
Role EVP, Global IT
Type Security Shares Price Value
holding Stock Options (Right to Buy) -- -- --
holding Stock Options (Right to Buy) -- -- --
Holdings After Transaction: Stock Options (Right to Buy) — 464,902 shares (Direct)
Footnotes (1)
  1. The stock options are fully vested and exercisable. The stock options vest in three equal annual installments from the April 4, 2024, grant date. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
Underlying shares (grant 1) 464,902 shares Stock options over Ordinary Shares at $9.39 exercise price
Exercise price (grant 1) $9.39 per share Stock options expiring February 8, 2027
Underlying shares (grant 2) 620,177 shares Stock options over Ordinary Shares at $5.87 exercise price
Exercise price (grant 2) $5.87 per share Stock options expiring April 4, 2029
Total underlying shares 1,085,079 shares Sum of underlying Ordinary Shares across both option grants
Exchange rate used $1.00 = NIS 3.149 Bank of Israel representative rate for exercise price conversion
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
Ordinary Shares financial
"underlying_security_title: Ordinary Shares"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
exercise price financial
"Represents an exercise price of NIS 29.57, converted to U.S. dollars"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in three equal annual installments financial
"The stock options vest in three equal annual installments from the April 4, 2024, grant date."
Trustee financial
"The options are held by a Trustee in the name of the Reporting Person."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Mishor MIRIAM
(Last)(First)(Middle)
C/O ICL GROUP LTD.
MILLENNIUM TOWER, 23 ARENHA ST.
(Street)
TEL AVIV6120201
(City)(State)(Zip)
ISRAEL
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026		3. Issuer Name and Ticker or Trading Symbol
ICL Group Ltd. [ ICL ]
3a. Foreign Trading Symbol
[ICL] 		5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Global IT
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy) (1)02/08/2027Ordinary Shares464,902$9.39(3)D(4)
Stock Options (Right to Buy) (2)04/04/2029Ordinary Shares620,177$5.87(5)D(4)
Explanation of Responses:
1. The stock options are fully vested and exercisable.
2. The stock options vest in three equal annual installments from the April 4, 2024, grant date.
3. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
4. The options are held by a Trustee in the name of the Reporting Person.
5. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
/s/ Mishor Miriam03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does the ICL Form 3 filing by Mishor Miriam report?

The Form 3 for ICL (ICL) reports Mishor Miriam’s existing stock option holdings. It lists two option grants over ICL Ordinary Shares, detailing exercise prices, expiration dates, vesting schedules, and that the positions are held as direct beneficial ownership.

How many ICL shares are covered by Mishor Miriam’s reported stock options?

The filing shows options over 1,085,079 ICL Ordinary Shares in total. This includes 464,902 shares under one grant and 620,177 shares under a second grant, giving a sense of the executive’s derivative-based exposure to ICL equity.

What are the exercise prices of Mishor Miriam’s ICL stock options?

One ICL option grant has an exercise price of $9.39 per share, while the other is at $5.87 per share. Both U.S. dollar figures are converted from New Israeli Shekel amounts using a Bank of Israel representative exchange rate.

When do Mishor Miriam’s ICL stock options expire?

The Form 3 shows two expiration dates for the ICL options. The fully vested grant over 464,902 shares expires on February 8, 2027, and the second grant over 620,177 shares expires on April 4, 2029, defining the latest dates to exercise.

How do Mishor Miriam’s ICL stock options vest according to the Form 3?

One ICL option grant is fully vested and exercisable. The other vests in three equal annual installments starting from the April 4, 2024 grant date, meaning portions become exercisable each year over a three-year period.